Advanced in Agranulocytosis

Dr. Hirohisa Nakamae

Hematology
825 Eastlake Ave E, 
Seattle, WA 
Advanced in Agranulocytosis
825 Eastlake Ave E, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hirohisa Nakamae is a Hematologist in Seattle, Washington. Dr. Nakamae is rated as an Advanced provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 300 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Agranulocytosis.

Specialties
Hematology
Licenses
Internal Medicine in WA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: May 01, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

300 Total Publications

Efficacy of ibrutinib and diagnostic liver biopsy for idiopathic refractory ascites after allogeneic stem cell transplantation.
Efficacy of ibrutinib and diagnostic liver biopsy for idiopathic refractory ascites after allogeneic stem cell transplantation.
Journal: International journal of hematology
Published: June 08, 2025
Similar Doctors
Distinguished in Agranulocytosis
Dr. Ron Ram
Hematology
Distinguished in Agranulocytosis
Dr. Ron Ram
Hematology
825 Eastlake Ave E, 
Seattle, WA 
 (0.1 miles away)
206-288-1000
Languages Spoken:
English

Ron Ram is a Hematologist in Seattle, Washington. Dr. Ram is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.

Distinguished in Agranulocytosis
Dr. Sibel Blau
Hematology Oncology | Hematology | Oncology
Distinguished in Agranulocytosis
Dr. Sibel Blau
Hematology Oncology | Hematology | Oncology

Northwest Medical Specialties PLLC

34509 9th Ave S, Suite 107, 
Federal Way, WA 
 (23.1 miles away)
253-428-8700
Languages Spoken:
English, Bengali, Filipino, Hindi, Italian, Japanese, Portuguese, Punjabi, Spanish, Turkish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Sibel Blau is a Hematologist Oncology specialist and a Hematologist in Federal Way, Washington. Dr. Blau is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and Pleuropulmonary Blastoma. Dr. Blau is currently accepting new patients.

Distinguished in Agranulocytosis
Dr. Andrea L. Veatch
Hematology Oncology | Oncology | Hematology
Distinguished in Agranulocytosis
Dr. Andrea L. Veatch
Hematology Oncology | Oncology | Hematology

Northwest Medical Specialties PLLC

1624 S I St, 
Tacoma, WA 
 (26.8 miles away)
253-428-8700
Languages Spoken:
English, French, Konkani, Malayalam, Spanish, Turkish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrea Veatch is a Hematologist Oncology specialist and an Oncologist in Tacoma, Washington. Dr. Veatch is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Dehydration, and Testicular Yolk Sac Tumor. Dr. Veatch is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nakamae's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 10 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile